Equities

Amgen Inc

0R0T:LSE

Amgen Inc

  • Price (USD)380.08
  • Today's Change13.52 / 3.69%
  • Shares traded2.73k
  • 1 Year change26.48%
  • Beta0.4591
Data delayed at least 20 minutes, as of Feb 06 2026 19:14 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Amgen Inc grew revenues 9.95% from 33.42bn to 36.75bn while net income improved 88.53% from 4.09bn to 7.71bn.
Gross margin73.30%
Net profit margin20.98%
Operating margin25.43%
Return on assets8.45%
Return on equity106.10%
Return on investment11.52%
More ▼

Cash flow in USDView more

In 2025, cash reserves at Amgen Inc fell by 2.84bn. However, the company earned 9.96bn from its operations for a Cash Flow Margin of 27.10%. In addition the company used 1.94bn on investing activities and also paid 10.86bn in financing cash flows.
Cash flow per share19.31
Price/Cash flow per share19.78
Book value per share16.06
Tangible book value per share-59.92
More ▼

Balance sheet in USDView more

Amgen Inc has a Debt to Total Capital ratio of 86.31%, a lower figure than the previous year's 962.21%.
Current ratio1.14
Quick ratio0.8958
Total debt/total equity6.31
Total debt/total capital0.8631
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)3.07%
Div growth rate (5 year)8.27%
Payout ratio (TTM)31.69%
EPS growth(5 years)2.93
EPS (TTM) vs
TTM 1 year ago		88.56
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.